These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16791660)

  • 41. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough.
    Rodriguez A; Lisboa T; Blot S; Martin-Loeches I; Solé-Violan J; De Mendoza D; Rello J;
    Intensive Care Med; 2009 Mar; 35(3):430-8. PubMed ID: 19066850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decrease in drug resistance in pneumococcal community-acquired pneumonia.
    Obando I; Arroyo L; Sanchez-Tatay D
    Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101
    [No Abstract]   [Full Text] [Related]  

  • 43. [The utility of the Pneumonia PORT prediction rule for evaluating the severity of community-acquired pneumonia in Japan. The relationship between disease severity and drug-resistant Streptococcus pneumoniae].
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura M; Shimizu J
    Kansenshogaku Zasshi; 2002 Dec; 76(12):1003-9. PubMed ID: 12607346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
    Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute community-acquired pneumonia. A review of clinical trials].
    Chidiac C
    Med Mal Infect; 2006; 36(11-12):650-66. PubMed ID: 16876363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
    Bédos JP; Bruneel F
    Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia.
    Spindler C; Ortqvist A
    Eur Respir J; 2006 Oct; 28(4):816-23. PubMed ID: 16737983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients.
    Messika J; Sztrymf B; Bertrand F; Billard-Pomares T; Barnaud G; Branger C; Dreyfuss D; Ricard JD
    J Crit Care; 2014 Oct; 29(5):733-8. PubMed ID: 24997726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
    Mufson MA; Stanek RJ
    Clin Infect Dis; 2006 Jan; 42(2):304-6. PubMed ID: 16355349
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
    Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
    J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy for community-acquired pneumonia in the elderly.
    Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
    Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.
    Mandell LA; Bartlett JG; Dowell SF; File TM; Musher DM; Whitney C;
    Clin Infect Dis; 2003 Dec; 37(11):1405-33. PubMed ID: 14614663
    [No Abstract]   [Full Text] [Related]  

  • 56. Hidden epidemic of macrolide-resistant pneumococci.
    Klugman KP; Lonks JR
    Emerg Infect Dis; 2005 Jun; 11(6):802-7. PubMed ID: 15963272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
    Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance.
    Moroney JF; Fiore AE; Harrison LH; Patterson JE; Farley MM; Jorgensen JH; Phelan M; Facklam RR; Cetron MS; Breiman RF; Kolczak M; Schuchat A
    Clin Infect Dis; 2001 Sep; 33(6):797-805. PubMed ID: 11512085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.